The three-month results show meaningful pain relief using a lower-energy variation of the company's Differential Target ...
In a one-on-one interview with MD+DI, Dexcom CEO Kevin Sayer shares the company's biggest lesson from 2021, expectations for ...
The Danvers, MA-based company reported successful results of the VENUS-HF Early feasibility study of the precardiac system.
With the growth of digital health comes a bevy of apps for different devices and health goals. The innovation is ...
The acquisition expands Medtronic's portfolio of advanced cardiac ablation products and accessories, including first-time ...
The Australian government is investing A$106 million over four years to support permanent telehealth services, but the ...
Quickly catch up on the latest medtech news from Dexcom, iRhythm, J&J, and others. At the J.P. Morgan Health Care Conference, ...
A close look at FDA's transition measures for devices under EUA's and COVID-19 policies. On Jan. 31, 2020, the Department of ...
The proceeds from the $75 million funding will be used for the European launch of the company’s updated Kaleido insulin patch ...
FDA backlog has delayed potential approval timing for Senseonics' 180-day Eversense continuous glucose monitor. A decision ...
The strategy, which involves donor blood used for stem cell grafts was published in the Journal of Oncology. Removing one ...
Dr. Lishan Aklog stops by Let’s Talk Medtech to discuss the impact of Lucid Diagnostics and being CEO of two companies during ...